Both in Pharmaceuticals
CorMedix vs Prothena
Over the past year CRMD returned −50.4% and PRTA returned −18.2%; their daily moves had a correlation of 0.22.
CRMD −50.4% PRTA −18.2%Growth of $1, one year, split-adjusted
| Metric | CRMD | PRTA |
|---|---|---|
| Price | $5.66 | $8.39 |
| Market cap | $441.2M | $430.7M |
| Today | +1.80% | +2.19% |
| 1 month | −22.3% | +4.6% |
| 6 months | −29.7% | −25.0% |
| Year to date | −51.3% | −12.1% |
| 1 year | −51.0% | −20.4% |
| Revenue growth (YoY) | +156.5% | −77.1% |
| Gross margin | 75.7% | 100.0% |
| Net margin | 25.5% | −1839.9% |
| P/E (TTM) | 2.4× | — |
| Price / sales | 1.0× | 7.9× |
| Net cash | $256.7M | $288.2M |
| Dividend yield | — | — |
| Volatility (60d) | 77.3% | 45.9% |
| Short % of float | 20.8% | 18.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).